Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-198-5 | CAS number: 64742-94-5 A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165°C to 290°C (330°F to 554°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Non-GLP, non-guideline animal experimental study, published in peer reviewed literature, minor restrictions in reporting but otherwise adequate for assessment.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- The role of toxicokinetics in xylene-induced ototoxicity in the rat and guinea pig
- Author:
- Gagnaire F, Marignac B, Blachere V, Grossman S and Langlais C
- Year:
- 2 007
- Bibliographic source:
- Toxicology 231, 147-158
Materials and methods
- Objective of study:
- toxicokinetics
Test guideline
- Qualifier:
- no guideline followed
- GLP compliance:
- not specified
Test material
- Reference substance name:
- o-xylene
- EC Number:
- 202-422-2
- EC Name:
- o-xylene
- Cas Number:
- 95-47-6
- Molecular formula:
- C8H10
- IUPAC Name:
- o-xylene
- Details on test material:
- - Source: Acros, Geel, Belgium
- Purity: 99% (for all)
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Iffa Credo, Saint-Germain-sur-l'Arbresle, France
- Age at study initiation: approx. 7 wk
- Housing: group housed, 4/cage in polypropylene cages with woodchip bedding
- Diet : UAR-Alimentation, Epinay-sur Orge, France, sterilised by gamma irradiation ad libitum
- Water : filtered tap water ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22°C
- Humidity: 50-60%
- Photoperiod (lights on): 07.00 - 19.00 hr
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on exposure:
- Each isomer administered to 48 rats by gavage at 8.47 mmol/kg (in olive oil, 4 mL/kg bw) 5 d/wk for 2 wk.
- Duration and frequency of treatment / exposure:
- daily, 5 d/wk for 2 wk
Doses / concentrations
- Remarks:
- Doses / Concentrations:
8.47 mmol/kg (899 mg/kg)
- No. of animals per sex per dose / concentration:
- 48
- Control animals:
- no
- Details on study design:
- Blood and brain concentrations of ortho, meta and para-xylene (one isomer per experiment) were determined in SD rats following sub-acute oral administration at 8.47 mmol/kg bw, 5 d/wk for 2 wk. Results for o-xylene only are reported here to permit comparison of toxicokinetics. Comment: 8.47 mmol p-xylene / kg bw shown previously to cause histological lesions of the organ of Corti in rats whereas m- and o-xylenes ineffective (see Gagnaire and Langlais (2005) Arch. Toxicol. 79, 346-354).
- Details on dosing and sampling:
- - Tissues and body fluids sampled: blood (abdominal aorta) and brain sampled on last day of treatment
- From how many animals: 6-8 per timepoint
- Time and frequency of sampling: 0.5, 1, 2, 5, 8, 11, 15 and 24 hr after final treatment
- Other: samples taken under deep anaesthesia (sodium pentobarbital) and stored frozen until analysis
- Method type(s) for identification: GC-FID - Statistics:
- Elimination half-life was estimated during the linear phase post-treatment. Maximum blood and brain concentrations were compared by one-way ANOVA followed by Scheffe's multiple range test if results were significant.
Results and discussion
Toxicokinetic / pharmacokinetic studies
Toxicokinetic parametersopen allclose all
- Toxicokinetic parameters:
- Cmax: Blood: o-xylene = 27 µg/mL
- Toxicokinetic parameters:
- Cmax: Brain: o-xylene = 101 µg/g
- Toxicokinetic parameters:
- half-life 1st: Blood: o-xylene = 181 min
- Toxicokinetic parameters:
- half-life 1st: Brain: o-xylene = 186 min
- Toxicokinetic parameters:
- AUC: Blood: o-xylene = 12960
- Toxicokinetic parameters:
- AUC: Brain: o-xylene = 43560
Any other information on results incl. tables
Graphical data revealed that concentrations of o-xylene peaked in blood and brain after 2 hr and then declined steadily over time. Levels in brain (Cmax, AUC) were 3-4 fold higher than in blood.
Applicant's summary and conclusion
- Conclusions:
- Blood and brain concentrations of o-xylene were determined in young adult male Sprague-Dawley rats following sub-acute oral gavage administration (8.47 mmol/kg bw/d, 5 d/wk for 2 wk). Levels of o-xylene in brain (Cmax, AUC) were 3-4 fold higher than in blood. Concentrations of peaked in blood and brain after 2 hr and then declined steadily over time.
- Executive summary:
Blood and brain concentrations of o-xylene were determined in young adult male Sprague-Dawley rats following sub-acute oral gavage administration (8.47 mmol/kg bw/d, 5 d/wk for 2 wk). Levels of o-xylene in brain (Cmax, AUC) were 3-4 fold higher than in blood. Concentrations of o-xylene peaked in blood and brain after 2 hr and then declined steadily over time.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.